US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

79.67

-2.5400-3.09%

Volume:681.07K

Turnover:54.71M

Market Cap:6.55B

PE:-22.47

High:83.41

Open:82.41

Low:79.07

Close:82.21

52wk High:103.00

52wk Low:28.06

Shares:82.26M

Float Shares:54.63M

Volume Ratio:1.64

T/O Rate:1.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.5458

EPS(LYR):-3.6900

ROE:-27.09%

ROA:-17.16%

PB:4.26

PE(LYR):-21.59

Loading ...

Overview Company News Filings

Kymera presents Phase 1b data for KT-621 STAT6 degrader in atopic dermatitis

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral Stat6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

THOMSON REUTERS

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

Kymera Therapeutics director Elena Ridloff disposes of 3,000 shares for $261,000

Kymera Therapeutics Initiated at Buy by Canaccord Genuity

Canaccord Genuity Initiates Kymera Therapeutics at Buy With $106 Price Target

MT Newswires Live

Kymera Therapeutics to join Bank of America Healthcare Conference fireside chat

Kymera says KT-579 Phase 1 healthy-volunteer trial data due in 2H 2026

Jeito Capital appoints Elaine Caughey partner for business development, investor relations

Barclays Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)

Kymera Therapeutics price target lowered to $119 from $123 at Morgan Stanley

Earnings Flash (KYMR) Kymera Therapeutics Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.88 Loss

MT Newswires Live

Kymera publishes corporate presentation on oral protein degraders for immunology medicines

Kymera Therapeutics Q1 EPS $(0.71) Beats $(0.88) Estimate, Sales $34.365M Beat $8.614M Estimate

Kymera Q1 revenue jumps on Gilead milestone

Kymera Q1 net loss widens to $69.2 million; collaboration revenues climb to $34.4 million

BRIEF-Kymera Therapeutics Q1 EPS USD -0.71

Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

Kymera CEO Nello Mainolfi disposes of common shares worth $2,430,898.39

Kymera director Bruce Booth disposes of common shares worth $538,687

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KYMR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":79.67,"timestamp":1779134400000,"preClose":82.21,"halted":0,"volume":681072,"delay":0,"changeRate":-0.030896484612577452,"floatShares":54626600,"shares":82257588,"eps":-3.545844,"marketStatus":"Pre-Mkt","change":-2.54,"latestTime":"05-19 06:45:23 EDT","open":82.41,"high":83.41,"low":79.07,"amount":54711824.142528,"amplitude":0.052792,"askPrice":108.47,"askSize":100,"bidPrice":71,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-3.545844,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"adr":0,"listingDate":1597982400000,"exchange":"NASDAQ","adjPreClose":79.67,"postHourTrading":{"tag":"盘后","latestPrice":79.67,"preClose":79.67,"latestTime":"17:44 EDT","volume":11147,"amount":888081.49,"timestamp":1779140644897,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6406028683001244,"impliedVol":0.6227,"impliedVolPercentile":0.22},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","floatShares":54626600,"roa":"-17.16%","roe":"-27.09%","lyrEps":-3.69,"volumeRatio":1.6406028683001244,"shares":82257588,"dividePrice":0,"high":83.41,"amplitude":0.052792,"preClose":82.21,"low":79.07,"week52Low":28.06,"pbRate":"4.26","psRate":"127.31","week52High":103,"institutionHeld":0,"latestPrice":79.67,"committee":-0.904762,"eps":-3.545844,"divideRate":0,"volume":681072,"delay":0,"ttmEps":-3.545844,"open":82.41,"prevYearClose":77.81,"prevWeekClose":82.21,"prevMonthClose":81.07,"prevQuarterClose":83.29,"fiveDayClose":84.1,"twentyDayClose":86.93,"sixtyDayClose":87.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-30","symbol":"KYMR","fiscalQuarterEnding":"2026/03","expectedEps":-0.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"KYMR","fiscalQuarterEnding":"2025/12","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.97},{"market":"US","date":"2025-11-04","symbol":"KYMR","fiscalQuarterEnding":"2025/09","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-11","symbol":"KYMR","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-05-09","symbol":"KYMR","fiscalQuarterEnding":"2025/03","expectedEps":-0.92,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.5833,"hold":0.0417,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":24,"updateTime":1778299200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYMR","date":"2026-05-15","current":-22.468558,"percent":0.198718,"low":-64.746367,"twenty":-22.052131,"median":-13.732985,"eighty":-9.124493,"high":-3.789687,"avg":-18.024721,"sd":12.895927,"marketCap":6950766186},"quantilePoints":[{"date":"2021-05-21","current":-42.117999,"twenty":-61.836945,"median":-43.894478,"eighty":-32.168393,"marketCap":2010544821},{"date":"2021-05-28","current":-45.271672,"twenty":-61.816988,"median":-43.735893,"eighty":-32.577826,"marketCap":2161088521},{"date":"2021-06-04","current":-44.904528,"twenty":-61.609434,"median":-43.980582,"eighty":-32.809006,"marketCap":2143562538},{"date":"2021-06-11","current":-47.587503,"twenty":-61.509649,"median":-44.22865,"eighty":-33.365155,"marketCap":2271637029},{"date":"2021-06-18","current":-44.57504,"twenty":-60.859049,"median":-44.457366,"eighty":-33.549298,"marketCap":2127834092},{"date":"2021-06-25","current":-41.779097,"twenty":-60.63553,"median":-44.248307,"eighty":-33.646073,"marketCap":1994366990},{"date":"2021-07-02","current":-58.674121,"twenty":-60.01287,"median":-44.377347,"eighty":-33.867539,"marketCap":2800867837},{"date":"2021-07-09","current":-54.868569,"twenty":-59.394201,"median":-44.639425,"eighty":-33.945704,"marketCap":2619206021},{"date":"2021-07-16","current":-52.206763,"twenty":-59.039657,"median":-44.866872,"eighty":-34.109477,"marketCap":2492142018},{"date":"2021-07-23","current":-60.462522,"twenty":-59.549606,"median":-44.91059,"eighty":-34.250917,"marketCap":2886238964},{"date":"2021-07-30","current":-62.573252,"twenty":-60.456284,"median":-45.023652,"eighty":-34.30861,"marketCap":2986996747},{"date":"2021-08-06","current":-51.928779,"twenty":-60.974802,"median":-45.464658,"eighty":-34.365027,"marketCap":3033004215},{"date":"2021-08-13","current":-47.068364,"twenty":-60.651495,"median":-45.711642,"eighty":-34.525867,"marketCap":2749121952},{"date":"2021-08-20","current":-46.841487,"twenty":-60.525339,"median":-45.681179,"eighty":-34.643843,"marketCap":2735870715},{"date":"2021-08-27","current":-52.583234,"twenty":-60.456284,"median":-45.761534,"eighty":-34.80179,"marketCap":3071228936},{"date":"2021-09-03","current":-52.39126,"twenty":-60.097568,"median":-46.12249,"eighty":-34.975392,"marketCap":3060016351},{"date":"2021-09-10","current":-58.167912,"twenty":-59.789796,"median":-46.231492,"eighty":-35.068445,"marketCap":3397413224},{"date":"2021-09-17","current":-54.930544,"twenty":-59.674378,"median":-46.53986,"eighty":-35.246583,"marketCap":3208328270},{"date":"2021-09-24","current":-54.537871,"twenty":-59.587037,"median":-46.809695,"eighty":-35.522327,"marketCap":3185393437},{"date":"2021-10-01","current":-52.54833,"twenty":-59.317994,"median":-46.890871,"eighty":-35.686253,"marketCap":3069190284},{"date":"2021-10-08","current":-48.51689,"twenty":-59.054061,"median":-47.083511,"eighty":-35.748479,"marketCap":2833726002},{"date":"2021-10-15","current":-49.91306,"twenty":-58.876157,"median":-47.068364,"eighty":-35.81053,"marketCap":2915272074},{"date":"2021-10-22","current":-48.586699,"twenty":-58.513954,"median":-47.083511,"eighty":-35.888209,"marketCap":2837803305},{"date":"2021-10-29","current":-51.379038,"twenty":-58.231387,"median":-47.634572,"eighty":-36.031291,"marketCap":3000895449},{"date":"2021-11-05","current":-56.66703,"twenty":-57.962548,"median":-47.834805,"eighty":-36.268304,"marketCap":3309751197},{"date":"2021-11-12","current":-40.862951,"twenty":-57.592374,"median":-47.792627,"eighty":-36.643399,"marketCap":3228254889},{"date":"2021-11-19","current":-39.959795,"twenty":-57.394247,"median":-47.611037,"eighty":-37.018397,"marketCap":3156903732},{"date":"2021-11-26","current":-34.950201,"twenty":-57.231083,"median":-47.083511,"eighty":-36.522189,"marketCap":2761135800},{"date":"2021-12-03","current":-34.534359,"twenty":-57.176853,"median":-46.939001,"eighty":-35.85679,"marketCap":2728283469},{"date":"2021-12-10","current":-34.469384,"twenty":-57.023938,"median":-46.854693,"eighty":-35.731094,"marketCap":2723150292},{"date":"2021-12-17","current":-35.067157,"twenty":-56.895652,"median":-46.777903,"eighty":-35.441994,"marketCap":2770375518},{"date":"2021-12-23","current":-40.135228,"twenty":-56.832825,"median":-46.53986,"eighty":-35.508989,"marketCap":3170763309},{"date":"2021-12-31","current":-41.252803,"twenty":-56.832825,"median":-46.231492,"eighty":-35.541476,"marketCap":3259053950},{"date":"2022-01-07","current":-36.100264,"twenty":-56.728112,"median":-46.187032,"eighty":-35.667949,"marketCap":2851993030},{"date":"2022-01-14","current":-26.685346,"twenty":-56.71066,"median":-46.004337,"eighty":-35.425245,"marketCap":2108195711},{"date":"2022-01-21","current":-24.716595,"twenty":-56.675756,"median":-45.799762,"eighty":-35.072355,"marketCap":1952660454},{"date":"2022-01-28","current":-25.002486,"twenty":-56.639106,"median":-45.704713,"eighty":-34.970993,"marketCap":1975246432},{"date":"2022-02-04","current":-25.814677,"twenty":-56.535547,"median":-45.445318,"eighty":-34.855337,"marketCap":2039411142},{"date":"2022-02-11","current":-27.315606,"twenty":-56.458749,"median":-45.224602,"eighty":-34.521364,"marketCap":2157987526},{"date":"2022-02-18","current":-25.210407,"twenty":-56.1271,"median":-44.939951,"eighty":-34.265806,"marketCap":1991672598},{"date":"2022-02-25","current":-20.657659,"twenty":-56.016065,"median":-44.903954,"eighty":-33.945704,"marketCap":2070248565},{"date":"2022-03-04","current":-18.502704,"twenty":-55.854061,"median":-44.772733,"eighty":-33.283828,"marketCap":1854285526},{"date":"2022-03-11","current":-19.812174,"twenty":-55.682188,"median":-44.495341,"eighty":-32.324854,"marketCap":1985516655},{"date":"2022-03-18","current":-22.317695,"twenty":-55.576416,"median":-44.339691,"eighty":-30.931725,"marketCap":2236612438},{"date":"2022-03-25","current":-20.843253,"twenty":-55.509604,"median":-44.227687,"eighty":-29.91279,"marketCap":2088848253},{"date":"2022-04-01","current":-21.477366,"twenty":-55.415713,"median":-43.894478,"eighty":-29.09307,"marketCap":2152397186},{"date":"2022-04-08","current":-18.368664,"twenty":-55.256898,"median":-43.540327,"eighty":-28.991566,"marketCap":1840852418},{"date":"2022-04-14","current":-19.611114,"twenty":-55.165513,"median":-43.260183,"eighty":-28.567245,"marketCap":1965366993},{"date":"2022-04-22","current":-17.46647,"twenty":-55.132037,"median":-42.908771,"eighty":-28.180145,"marketCap":1750437270},{"date":"2022-04-29","current":-16.167875,"twenty":-55.087613,"median":-42.53692,"eighty":-27.835849,"marketCap":1620295970},{"date":"2022-05-06","current":-7.934642,"twenty":-55.003842,"median":-42.089758,"eighty":-27.620703,"marketCap":982514932},{"date":"2022-05-13","current":-7.267865,"twenty":-54.946251,"median":-41.906186,"eighty":-27.280132,"marketCap":899950652},{"date":"2022-05-20","current":-6.163516,"twenty":-54.905754,"median":-41.694372,"eighty":-27.026289,"marketCap":763203563},{"date":"2022-05-27","current":-6.271867,"twenty":-54.823551,"median":-41.430782,"eighty":-26.775569,"marketCap":776620258},{"date":"2022-06-03","current":-6.442729,"twenty":-54.717338,"median":-41.342758,"eighty":-26.099247,"marketCap":797777355},{"date":"2022-06-10","current":-6.209357,"twenty":-54.557652,"median":-41.120121,"eighty":-25.818576,"marketCap":768879857},{"date":"2022-06-17","current":-6.571917,"twenty":-54.511693,"median":-40.89219,"eighty":-25.245293,"marketCap":813774184},{"date":"2022-06-24","current":-8.388883,"twenty":-54.40698,"median":-40.800208,"eighty":-25.002486,"marketCap":1038761847},{"date":"2022-07-01","current":-8.793116,"twenty":-54.382983,"median":-40.668026,"eighty":-24.716595,"marketCap":1088816442},{"date":"2022-07-08","current":-10.985145,"twenty":-54.363863,"median":-40.651043,"eighty":-23.157688,"marketCap":1360246513},{"date":"2022-07-15","current":-9.680763,"twenty":-54.250803,"median":-40.300689,"eighty":-21.912481,"marketCap":1198730140},{"date":"2022-07-22","current":-9.047325,"twenty":-53.993365,"median":-40.141071,"eighty":-21.396942,"marketCap":1120294074},{"date":"2022-07-29","current":-9.18068,"twenty":-53.858983,"median":-39.89482,"eighty":-20.83088,"marketCap":1136806930},{"date":"2022-08-05","current":-12.989642,"twenty":-53.679227,"median":-39.157098,"eighty":-20.482375,"marketCap":1608455379},{"date":"2022-08-12","current":-12.493565,"twenty":-53.411973,"median":-38.789003,"eighty":-19.900847,"marketCap":1741890302},{"date":"2022-08-19","current":-11.838735,"twenty":-53.337979,"median":-38.465388,"eighty":-19.728657,"marketCap":1650591936},{"date":"2022-08-26","current":-12.117757,"twenty":-53.305752,"median":-38.163943,"eighty":-19.253329,"marketCap":1689493966},{"date":"2022-09-02","current":-10.712799,"twenty":-53.124249,"median":-37.899038,"eighty":-18.792437,"marketCap":1493610607},{"date":"2022-09-09","current":-11.456778,"twenty":-53.075383,"median":-37.802616,"eighty":-18.455274,"marketCap":1597338383},{"date":"2022-09-16","current":-10.113974,"twenty":-53.00383,"median":-37.690264,"eighty":-18.059341,"marketCap":1410120528},{"date":"2022-09-23","current":-8.466696,"twenty":-52.853783,"median":-37.393272,"eighty":-17.438079,"marketCap":1180452113},{"date":"2022-09-30","current":-8.497924,"twenty":-52.783961,"median":-37.338809,"eighty":-16.517073,"marketCap":1184806017},{"date":"2022-10-07","current":-7.928012,"twenty":-52.663514,"median":-36.555091,"eighty":-13.054653,"marketCap":1105347276},{"date":"2022-10-14","current":-8.587704,"twenty":-52.572763,"median":-36.180368,"eighty":-12.555718,"marketCap":1197323490},{"date":"2022-10-21","current":-9.758755,"twenty":-52.555311,"median":-36.074274,"eighty":-11.951943,"marketCap":1360594875},{"date":"2022-10-28","current":-11.706602,"twenty":-52.454088,"median":-35.903918,"eighty":-11.606672,"marketCap":1632169612},{"date":"2022-11-04","current":-10.95052,"twenty":-52.280562,"median":-35.713709,"eighty":-11.366217,"marketCap":1684660854},{"date":"2022-11-11","current":-10.961165,"twenty":-52.141445,"median":-35.525233,"eighty":-11.186385,"marketCap":1686298568},{"date":"2022-11-18","current":-10.233733,"twenty":-52.033077,"median":-35.425245,"eighty":-11.029695,"marketCap":1574388174},{"date":"2022-11-25","current":-9.854049,"twenty":-51.965429,"median":-35.127475,"eighty":-10.972797,"marketCap":1515976407},{"date":"2022-12-02","current":-10.922132,"twenty":-51.872694,"median":-35.050913,"eighty":-10.933487,"marketCap":1680293620},{"date":"2022-12-09","current":-9.190488,"twenty":-51.760368,"median":-34.976191,"eighty":-10.762271,"marketCap":1413892292},{"date":"2022-12-16","current":-10.027923,"twenty":-51.690661,"median":-34.886786,"eighty":-10.631224,"marketCap":1542725721},{"date":"2022-12-23","current":-9.396298,"twenty":-51.643683,"median":-34.761773,"eighty":-10.461765,"marketCap":1445554745},{"date":"2022-12-30","current":-8.856934,"twenty":-51.58372,"median":-34.61629,"eighty":-10.350133,"marketCap":1362577282},{"date":"2023-01-06","current":-9.697917,"twenty":-51.379038,"median":-34.469384,"eighty":-10.297605,"marketCap":1491956615},{"date":"2023-01-13","current":-12.25635,"twenty":-51.256873,"median":-34.303957,"eighty":-10.297605,"marketCap":1885553659},{"date":"2023-01-20","current":-12.419579,"twenty":-51.251155,"median":-34.181877,"eighty":-10.303283,"marketCap":1910665260},{"date":"2023-01-27","current":-13.076042,"twenty":-51.153931,"median":-33.917788,"eighty":-10.324573,"marketCap":2011657566},{"date":"2023-02-03","current":-13.182496,"twenty":-51.098859,"median":-33.526965,"eighty":-10.344455,"marketCap":2028034697},{"date":"2023-02-10","current":-11.780858,"twenty":-51.090271,"median":-32.866801,"eighty":-10.35598,"marketCap":1812402475},{"date":"2023-02-17","current":-11.947635,"twenty":-51.021067,"median":-32.298777,"eighty":-10.366287,"marketCap":1838059980},{"date":"2023-02-24","current":-11.157115,"twenty":-50.808509,"median":-31.070369,"eighty":-10.408947,"marketCap":1727210659},{"date":"2023-03-03","current":-11.639431,"twenty":-50.542187,"median":-30.891255,"eighty":-10.455157,"marketCap":1801877108},{"date":"2023-03-10","current":-10.49393,"twenty":-50.361636,"median":-30.284071,"eighty":-10.48353,"marketCap":1624544291},{"date":"2023-03-17","current":-11.008164,"twenty":-50.140894,"median":-29.544301,"eighty":-10.497824,"marketCap":1704151903},{"date":"2023-03-24","current":-10.401722,"twenty":-50.020892,"median":-29.090731,"eighty":-10.455157,"marketCap":1610269823},{"date":"2023-03-31","current":-10.508116,"twenty":-49.98944,"median":-28.999526,"eighty":-10.388384,"marketCap":1626740363},{"date":"2023-04-06","current":-10.586137,"twenty":-49.949709,"median":-28.985983,"eighty":-10.415431,"marketCap":1638818759},{"date":"2023-04-14","current":-11.841579,"twenty":-49.849014,"median":-28.581203,"eighty":-10.448769,"marketCap":1833171135},{"date":"2023-04-21","current":-12.008262,"twenty":-49.732136,"median":-28.390444,"eighty":-10.474075,"marketCap":1858974981},{"date":"2023-04-28","current":-11.157632,"twenty":-49.657868,"median":-28.116374,"eighty":-10.487547,"marketCap":1727290638},{"date":"2023-05-05","current":-9.075289,"twenty":-49.553375,"median":-27.841432,"eighty":-10.487547,"marketCap":1443442877},{"date":"2023-05-12","current":-9.718931,"twenty":-49.490296,"median":-27.737946,"eighty":-10.381714,"marketCap":1545815421},{"date":"2023-05-19","current":-10.225916,"twenty":-49.450579,"median":-27.590189,"eighty":-10.319099,"marketCap":1626452351},{"date":"2023-05-26","current":-9.987943,"twenty":-49.384446,"median":-27.302611,"eighty":-10.268406,"marketCap":1588602363},{"date":"2023-06-02","current":-10.139694,"twenty":-49.354964,"median":-27.236588,"eighty":-10.236831,"marketCap":1612738587},{"date":"2023-06-08","current":-8.746348,"twenty":-49.319688,"median":-27.124925,"eighty":-10.222467,"marketCap":1391124169},{"date":"2023-06-16","current":-9.543038,"twenty":-49.101536,"median":-26.951745,"eighty":-10.153489,"marketCap":1517839344},{"date":"2023-06-23","current":-8.080715,"twenty":-48.944671,"median":-26.910903,"eighty":-10.113974,"marketCap":1285253915},{"date":"2023-06-30","current":-7.725481,"twenty":-48.714201,"median":-26.678849,"eighty":-10.083132,"marketCap":1228753209},{"date":"2023-07-07","current":-7.642708,"twenty":-48.581174,"median":-26.094071,"eighty":-10.029342,"marketCap":1215587996},{"date":"2023-07-14","current":-7.687543,"twenty":-48.550488,"median":-25.843916,"eighty":-9.996276,"marketCap":1222719153},{"date":"2023-07-21","current":-7.418531,"twenty":-48.452515,"median":-25.736707,"eighty":-9.976784,"marketCap":1179932211},{"date":"2023-07-28","current":-7.642708,"twenty":-48.322595,"median":-25.297621,"eighty":-9.91863,"marketCap":1215587996},{"date":"2023-08-04","current":-8.325772,"twenty":-48.26907,"median":-25.145432,"eighty":-9.856413,"marketCap":1312091662},{"date":"2023-08-11","current":-7.046225,"twenty":-48.239401,"median":-24.892029,"eighty":-9.804457,"marketCap":1110442734},{"date":"2023-08-18","current":-6.596466,"twenty":-48.152272,"median":-24.716595,"eighty":-9.765337,"marketCap":1039563411},{"date":"2023-08-25","current":-6.746385,"twenty":-48.032791,"median":-23.741966,"eighty":-9.707694,"marketCap":1063189852},{"date":"2023-09-01","current":-6.65225,"twenty":-47.951039,"median":-22.317695,"eighty":-9.667636,"marketCap":1048354644},{"date":"2023-09-08","current":-6.613898,"twenty":-47.924458,"median":-21.936196,"eighty":-9.572037,"marketCap":1042310671},{"date":"2023-09-15","current":-6.756845,"twenty":-47.90723,"median":-21.639761,"eighty":-9.529071,"marketCap":1064838208},{"date":"2023-09-22","current":-6.056058,"twenty":-47.860111,"median":-21.384569,"eighty":-9.413184,"marketCap":954398332},{"date":"2023-09-29","current":-4.985701,"twenty":-47.781558,"median":-20.887073,"eighty":-9.333925,"marketCap":785716531},{"date":"2023-10-06","current":-5.484271,"twenty":-47.716741,"median":-20.688591,"eighty":-9.24394,"marketCap":864288184},{"date":"2023-10-13","current":-4.351157,"twenty":-47.625158,"median":-20.459176,"eighty":-9.174333,"marketCap":685716245},{"date":"2023-10-20","current":-4.145453,"twenty":-47.489734,"median":-20.157585,"eighty":-9.106984,"marketCap":653298570},{"date":"2023-10-27","current":-4.012966,"twenty":-47.294195,"median":-19.910127,"eighty":-9.072011,"marketCap":632419390},{"date":"2023-11-03","current":-3.963586,"twenty":-47.080481,"median":-19.830218,"eighty":-8.938402,"marketCap":663738160},{"date":"2023-11-10","current":-4.696304,"twenty":-47.063128,"median":-19.683289,"eighty":-8.857001,"marketCap":786438288},{"date":"2023-11-17","current":-5.904393,"twenty":-46.987256,"median":-19.373965,"eighty":-8.803369,"marketCap":988743705},{"date":"2023-11-24","current":-6.540402,"twenty":-46.919749,"median":-19.080109,"eighty":-8.726901,"marketCap":1095249134},{"date":"2023-12-01","current":-6.805952,"twenty":-46.878192,"median":-18.817183,"eighty":-8.686608,"marketCap":1139717896},{"date":"2023-12-08","current":-7.763244,"twenty":-46.855589,"median":-18.510438,"eighty":-8.598634,"marketCap":1300025038},{"date":"2023-12-15","current":-8.34352,"twenty":-46.846723,"median":-18.368664,"eighty":-8.460015,"marketCap":1397197517},{"date":"2023-12-22","current":-8.294344,"twenty":-46.816053,"median":-18.030986,"eighty":-8.361665,"marketCap":1388962561},{"date":"2023-12-29","current":-8.79266,"twenty":-46.777903,"median":-17.79126,"eighty":-8.388883,"marketCap":1472410114},{"date":"2024-01-05","current":-8.923796,"twenty":-46.766793,"median":-17.452275,"eighty":-8.343329,"marketCap":1494369997},{"date":"2024-01-12","current":-9.674507,"twenty":-46.627671,"median":-17.043728,"eighty":-8.370738,"marketCap":1620083291},{"date":"2024-01-19","current":-9.548135,"twenty":-46.523894,"median":-16.749871,"eighty":-8.403522,"marketCap":1598921100},{"date":"2024-01-26","current":-11.176934,"twenty":-46.396169,"median":-14.953625,"eighty":-8.429475,"marketCap":1871678229},{"date":"2024-02-02","current":-11.471803,"twenty":-46.233294,"median":-13.281852,"eighty":-8.443505,"marketCap":1921056675},{"date":"2024-02-09","current":-11.928148,"twenty":-46.219098,"median":-13.205561,"eighty":-8.460015,"marketCap":1997475698},{"date":"2024-02-16","current":-13.135706,"twenty":-46.203228,"median":-13.097993,"eighty":-8.479187,"marketCap":2199692190},{"date":"2024-02-23","current":-16.837086,"twenty":-46.159109,"median":-13.182496,"eighty":-8.497945,"marketCap":2474411842},{"date":"2024-03-01","current":-17.756077,"twenty":-46.044123,"median":-13.272981,"eighty":-8.508435,"marketCap":2609468650},{"date":"2024-03-08","current":-17.756077,"twenty":-46.020308,"median":-13.374413,"eighty":-8.557588,"marketCap":2609468650},{"date":"2024-03-15","current":-16.42957,"twenty":-45.949772,"median":-13.662373,"eighty":-8.593169,"marketCap":2414522397},{"date":"2024-03-22","current":-16.974311,"twenty":-45.822699,"median":-16.167875,"eighty":-8.619808,"marketCap":2494578695},{"date":"2024-03-28","current":-16.704019,"twenty":-45.761534,"median":-16.421253,"eighty":-8.638924,"marketCap":2454856105},{"date":"2024-04-05","current":-15.069795,"twenty":-45.711642,"median":-16.371353,"eighty":-8.670473,"marketCap":2214687210},{"date":"2024-04-12","current":-15.473153,"twenty":-45.704713,"median":-16.157001,"eighty":-8.686608,"marketCap":2273965538},{"date":"2024-04-19","current":-14.604062,"twenty":-45.657644,"median":-15.55632,"eighty":-8.686608,"marketCap":2146242131},{"date":"2024-04-26","current":-13.923994,"twenty":-45.5064,"median":-15.136328,"eighty":-8.687717,"marketCap":2046298037},{"date":"2024-05-03","current":-14.407727,"twenty":-45.384235,"median":-14.959599,"eighty":-8.704809,"marketCap":2227304910},{"date":"2024-05-10","current":-15.324582,"twenty":-45.271672,"median":-15.123853,"eighty":-8.713937,"marketCap":2369042495},{"date":"2024-05-17","current":-14.129892,"twenty":-45.224602,"median":-15.056286,"eighty":-8.746348,"marketCap":2184354127},{"date":"2024-05-24","current":-13.590098,"twenty":-45.023652,"median":-14.844325,"eighty":-8.77228,"marketCap":2100906890},{"date":"2024-05-31","current":-12.744686,"twenty":-44.975332,"median":-14.700565,"eighty":-8.788584,"marketCap":1970213792},{"date":"2024-06-07","current":-13.082057,"twenty":-44.925971,"median":-14.537498,"eighty":-8.793025,"marketCap":2022368315},{"date":"2024-06-14","current":-13.213037,"twenty":-44.906953,"median":-14.383912,"eighty":-8.797997,"marketCap":2042616541},{"date":"2024-06-21","current":-12.697057,"twenty":-44.90384,"median":-14.292624,"eighty":-8.805809,"marketCap":1962850801},{"date":"2024-06-28","current":-11.847676,"twenty":-44.881476,"median":-14.217211,"eighty":-8.812693,"marketCap":1831544120},{"date":"2024-07-05","current":-12.006439,"twenty":-44.829216,"median":-14.127873,"eighty":-8.814742,"marketCap":1856087425},{"date":"2024-07-12","current":-16.789169,"twenty":-44.745164,"median":-14.169583,"eighty":-8.831969,"marketCap":2595454482},{"date":"2024-07-19","current":-17.106695,"twenty":-44.652302,"median":-14.288247,"eighty":-8.856979,"marketCap":2644541092},{"date":"2024-07-26","current":-17.678241,"twenty":-44.511281,"median":-14.383912,"eighty":-8.863292,"marketCap":2732896989},{"date":"2024-08-02","current":-16.685974,"twenty":-44.415386,"median":-14.439331,"eighty":-8.882836,"marketCap":2579501334},{"date":"2024-08-09","current":-16.211527,"twenty":-44.384878,"median":-14.691387,"eighty":-8.906376,"marketCap":2559054389},{"date":"2024-08-16","current":-17.13477,"twenty":-44.303137,"median":-14.819835,"eighty":-8.920794,"marketCap":2704792043},{"date":"2024-08-23","current":-19.297835,"twenty":-44.240444,"median":-15.042778,"eighty":-8.934868,"marketCap":3046240465},{"date":"2024-08-30","current":-19.532091,"twenty":-44.22788,"median":-15.130091,"eighty":-8.97565,"marketCap":3083218688},{"date":"2024-09-06","current":-18.336578,"twenty":-44.194716,"median":-15.213448,"eighty":-9.018995,"marketCap":2894502242},{"date":"2024-09-13","current":-18.611223,"twenty":-44.032244,"median":-15.280922,"eighty":-9.051279,"marketCap":2937856020},{"date":"2024-09-20","current":-20.109653,"twenty":-43.886709,"median":-15.45652,"eighty":-9.068733,"marketCap":3174389133},{"date":"2024-09-27","current":-19.665374,"twenty":-43.807738,"median":-15.639486,"eighty":-9.079877,"marketCap":3104258021},{"date":"2024-10-04","current":-17.391477,"twenty":-43.585821,"median":-15.656,"eighty":-9.106984,"marketCap":2745314241},{"date":"2024-10-11","current":-18.1831,"twenty":-43.426785,"median":-16.157001,"eighty":-9.143183,"marketCap":2870275131},{"date":"2024-10-18","current":-18.744507,"twenty":-43.269622,"median":-16.281044,"eighty":-9.152191,"marketCap":2958895353},{"date":"2024-10-25","current":-19.382652,"twenty":-43.188613,"median":-16.421253,"eighty":-9.17001,"marketCap":3059629132},{"date":"2024-11-01","current":-17.970803,"twenty":-42.953958,"median":-16.432042,"eighty":-9.174333,"marketCap":3009642282},{"date":"2024-11-08","current":-19.703301,"twenty":-42.897474,"median":-16.45452,"eighty":-9.181514,"marketCap":3299790710},{"date":"2024-11-15","current":-16.226703,"twenty":-42.824045,"median":-16.632072,"eighty":-9.185976,"marketCap":2717550897},{"date":"2024-11-22","current":-17.394593,"twenty":-42.641415,"median":-16.63794,"eighty":-9.198528,"marketCap":2913142024},{"date":"2024-11-29","current":-18.117756,"twenty":-42.362762,"median":-16.704019,"eighty":-9.230689,"marketCap":3034253086},{"date":"2024-12-06","current":-18.048147,"twenty":-42.117999,"median":-16.760212,"eighty":-9.274328,"marketCap":3022595337},{"date":"2024-12-13","current":-16.292445,"twenty":-42.089758,"median":-16.770553,"eighty":-9.296942,"marketCap":2728560993},{"date":"2024-12-20","current":-15.723969,"twenty":-42.026009,"median":-16.710256,"eighty":-9.297366,"marketCap":2633356040},{"date":"2024-12-27","current":-15.511274,"twenty":-41.948978,"median":-16.669034,"eighty":-9.299865,"marketCap":2597735140},{"date":"2025-01-03","current":-16.083617,"twenty":-41.901479,"median":-16.632072,"eighty":-9.317721,"marketCap":2693587745},{"date":"2025-01-10","current":-14.761041,"twenty":-41.841229,"median":-16.510768,"eighty":-9.338641,"marketCap":2472090508},{"date":"2025-01-17","current":-15.704633,"twenty":-41.745207,"median":-16.439891,"eighty":-9.354352,"marketCap":2630117777},{"date":"2025-01-24","current":-17.154827,"twenty":-41.651541,"median":-16.567015,"eighty":-9.358228,"marketCap":2872987554},{"date":"2025-01-31","current":-15.310181,"twenty":-41.477861,"median":-16.437202,"eighty":-9.370749,"marketCap":2564057197},{"date":"2025-02-07","current":-14.43233,"twenty":-41.453375,"median":-16.425411,"eighty":-9.413184,"marketCap":2417040025},{"date":"2025-02-14","current":-14.262174,"twenty":-41.388207,"median":-16.396436,"eighty":-9.48073,"marketCap":2388543305},{"date":"2025-02-21","current":-14.235104,"twenty":-41.36853,"median":-16.354374,"eighty":-9.48073,"marketCap":2384009735},{"date":"2025-02-28","current":-9.095045,"twenty":-41.316985,"median":-16.292445,"eighty":-9.48073,"marketCap":2035998663},{"date":"2025-03-07","current":-9.54182,"twenty":-41.252803,"median":-16.219115,"eighty":-9.364362,"marketCap":2136012633},{"date":"2025-03-14","current":-9.971187,"twenty":-41.120121,"median":-16.157001,"eighty":-9.396298,"marketCap":2232129954},{"date":"2025-03-21","current":-9.44028,"twenty":-41.064375,"median":-15.882524,"eighty":-9.44028,"marketCap":2113282185},{"date":"2025-03-28","current":-8.59315,"twenty":-40.921429,"median":-15.785844,"eighty":-9.356694,"marketCap":1923645308},{"date":"2025-04-04","current":-6.402796,"twenty":-40.862951,"median":-15.746717,"eighty":-9.297366,"marketCap":1433317081},{"date":"2025-04-11","current":-6.997528,"twenty":-40.836961,"median":-15.704633,"eighty":-9.230689,"marketCap":1566452560},{"date":"2025-04-17","current":-7.534237,"twenty":-40.778157,"median":-15.657984,"eighty":-9.184014,"marketCap":1686599211},{"date":"2025-04-25","current":-9.649161,"twenty":-40.687293,"median":-15.64736,"eighty":-9.172062,"marketCap":2160041963},{"date":"2025-05-02","current":-10.262501,"twenty":-40.668071,"median":-15.580884,"eighty":-9.179093,"marketCap":2297342930},{"date":"2025-05-09","current":-8.129065,"twenty":-40.65763,"median":-15.513208,"eighty":-9.146726,"marketCap":1958145409},{"date":"2025-05-16","current":-8.177726,"twenty":-40.651841,"median":-15.473153,"eighty":-9.07365,"marketCap":1969866932},{"date":"2025-05-23","current":-8.156099,"twenty":-40.649035,"median":-15.377323,"eighty":-8.951301,"marketCap":1964657366},{"date":"2025-05-30","current":-8.177726,"twenty":-40.441912,"median":-15.295552,"eighty":-8.913864,"marketCap":1969866932},{"date":"2025-06-06","current":-12.884311,"twenty":-40.299994,"median":-15.236704,"eighty":-8.913864,"marketCap":3103598610},{"date":"2025-06-13","current":-12.784286,"twenty":-40.274094,"median":-15.203654,"eighty":-8.921794,"marketCap":3079504370},{"date":"2025-06-20","current":-12.554499,"twenty":-40.211637,"median":-15.136243,"eighty":-8.934518,"marketCap":3024152737},{"date":"2025-06-27","current":-12.357152,"twenty":-40.138734,"median":-15.10522,"eighty":-8.95095,"marketCap":2976615453},{"date":"2025-07-03","current":-13.046424,"twenty":-40.100141,"median":-15.069795,"eighty":-8.963563,"marketCap":3142648605},{"date":"2025-07-11","current":-13.168761,"twenty":-39.933805,"median":-14.938931,"eighty":-9.018995,"marketCap":3172117514},{"date":"2025-07-18","current":-13.50082,"twenty":-39.812951,"median":-14.849403,"eighty":-9.051279,"marketCap":3252104551},{"date":"2025-07-25","current":-13.35518,"twenty":-39.627721,"median":-14.778193,"eighty":-9.068733,"marketCap":3217022517},{"date":"2025-08-01","current":-12.743493,"twenty":-39.147269,"median":-14.691387,"eighty":-9.07924,"marketCap":3069677975},{"date":"2025-08-08","current":-11.898781,"twenty":-39.064709,"median":-14.515474,"eighty":-9.095682,"marketCap":2866202177},{"date":"2025-08-15","current":-10.785615,"twenty":-38.850637,"median":-14.43233,"eighty":-9.106984,"marketCap":2970725155},{"date":"2025-08-22","current":-11.05558,"twenty":-38.768458,"median":-14.383912,"eighty":-9.124493,"marketCap":3045082656},{"date":"2025-08-29","current":-10.837532,"twenty":-38.768458,"median":-14.26484,"eighty":-9.124493,"marketCap":2985024674},{"date":"2025-09-05","current":-10.954343,"twenty":-38.809548,"median":-14.147693,"eighty":-9.115738,"marketCap":3017198593},{"date":"2025-09-12","current":-11.99267,"twenty":-38.768458,"median":-14.036722,"eighty":-9.124493,"marketCap":3303188981},{"date":"2025-09-19","current":-13.280194,"twenty":-38.768458,"median":-13.923994,"eighty":-9.124493,"marketCap":3657817062},{"date":"2025-09-26","current":-13.948617,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":3841923374},{"date":"2025-10-03","current":-14.536569,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4003865432},{"date":"2025-10-10","current":-14.801343,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4076792980},{"date":"2025-10-17","current":-15.694303,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4322744714},{"date":"2025-10-24","current":-14.993433,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4129701202},{"date":"2025-10-31","current":-15.948693,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4392812359},{"date":"2025-11-07","current":-14.871445,"twenty":-38.510575,"median":-13.732985,"eighty":-9.124493,"marketCap":4388890647},{"date":"2025-11-14","current":-15.512624,"twenty":-37.938352,"median":-13.732985,"eighty":-9.124493,"marketCap":4578116588},{"date":"2025-11-21","current":-15.756418,"twenty":-37.652889,"median":-13.732985,"eighty":-9.124493,"marketCap":4650065615},{"date":"2025-11-28","current":-16.548749,"twenty":-37.32898,"median":-13.732985,"eighty":-9.124493,"marketCap":4883899952},{"date":"2025-12-05","current":-16.146489,"twenty":-36.08467,"median":-13.732985,"eighty":-9.124493,"marketCap":4765184058},{"date":"2025-12-12","current":-23.802748,"twenty":-35.592065,"median":-13.732985,"eighty":-9.124493,"marketCap":7024714560},{"date":"2025-12-19","current":-21.585387,"twenty":-35.069756,"median":-13.732985,"eighty":-9.124493,"marketCap":6370322520},{"date":"2025-12-26","current":-22.534135,"twenty":-34.960597,"median":-13.732985,"eighty":-9.124493,"marketCap":6650319114},{"date":"2026-01-02","current":-21.092037,"twenty":-34.674483,"median":-13.732985,"eighty":-9.124493,"marketCap":6224724290},{"date":"2026-01-09","current":-20.324906,"twenty":-33.447973,"median":-13.732985,"eighty":-9.124493,"marketCap":5998327044},{"date":"2026-01-16","current":-19.278572,"twenty":-29.680357,"median":-13.732985,"eighty":-9.124493,"marketCap":5689530800},{"date":"2026-01-23","current":-19.725839,"twenty":-27.736646,"median":-13.732985,"eighty":-9.124493,"marketCap":5821529194},{"date":"2026-01-30","current":-20.03486,"twenty":-26.936151,"median":-13.732985,"eighty":-9.124493,"marketCap":5912728085},{"date":"2026-02-06","current":-20.585135,"twenty":-25.879653,"median":-13.732985,"eighty":-9.124493,"marketCap":6075126110},{"date":"2026-02-13","current":-22.775389,"twenty":-25.350754,"median":-13.732985,"eighty":-9.124493,"marketCap":6721518248},{"date":"2026-02-20","current":-23.447645,"twenty":-24.971298,"median":-13.732985,"eighty":-9.124493,"marketCap":6919915835},{"date":"2026-02-27","current":-24.821424,"twenty":-24.616503,"median":-13.732985,"eighty":-9.124493,"marketCap":7728175245},{"date":"2026-03-06","current":-21.900597,"twenty":-23.960592,"median":-13.732985,"eighty":-9.124493,"marketCap":6818772746},{"date":"2026-03-13","current":-20.322034,"twenty":-23.398123,"median":-13.732985,"eighty":-9.124493,"marketCap":6327285535},{"date":"2026-03-20","current":-20.864829,"twenty":-22.914822,"median":-13.732985,"eighty":-9.124493,"marketCap":6496285290},{"date":"2026-03-27","current":-21.024783,"twenty":-22.604919,"median":-13.732985,"eighty":-9.124493,"marketCap":6546087150},{"date":"2026-04-02","current":-22.270327,"twenty":-22.323196,"median":-13.732985,"eighty":-9.124493,"marketCap":6933888522},{"date":"2026-04-10","current":-22.904899,"twenty":-22.318613,"median":-13.732985,"eighty":-9.124493,"marketCap":7131463115},{"date":"2026-04-17","current":-22.587613,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7032675819},{"date":"2026-04-24","current":-22.857699,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7116767484},{"date":"2026-05-01","current":-21.011634,"twenty":-22.281865,"median":-13.732985,"eighty":-9.124493,"marketCap":6618748881},{"date":"2026-05-08","current":-22.099591,"twenty":-22.131175,"median":-13.732985,"eighty":-9.124493,"marketCap":6961459672},{"date":"2026-05-15","current":-22.065644,"twenty":-22.052131,"median":-13.732985,"eighty":-9.124493,"marketCap":6950766186}],"updateTime":1779175799781},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYMR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635086879","title":"Kymera presents Phase 1b data for KT-621 STAT6 degrader in atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2635086879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635086879?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:01","pubTimestamp":1778842883,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics set late-breaking and featured conference presentations for Phase 1b BroADen trial data on KT-621, its oral STAT6 degrader, at Society for Investigative Dermatology annual meeting and American Thoracic Society Respiratory Innovation Summit on May 16, 2026.Results have already been reported previously, showing target engagement in blood and skin, consistent shifts in disease-related inflammatory signals, early signs of clinical activity, and a safety profile viewed as supportive of continued development.New analyses to be presented focus on skin biology, pointing to strong local target engagement and broad downstream effects aligned with improvement in atopic dermatitis measures.Company also plans to highlight early evidence suggesting potential benefit in asthma based on biomarker changes and patient-reported outcomes observed in atopic dermatitis patients with comorbid asthma.Parallel Phase 2b trials in atopic dermatitis and asthma are ongoing, with readouts expect","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL2Txf8C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","BK4588","BK4139","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","IE00BN0W2W23.USD","BK4585","NDAQ","KYMR","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635085069","title":"Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral Stat6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2635085069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635085069?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:00","pubTimestamp":1778842801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUA3KS9P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635086190","title":"Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses","url":"https://stock-news.laohu8.com/highlight/detail?id=2635086190","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635086190?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:00","pubTimestamp":1778842800,"startTime":"0","endTime":"0","summary":"Late-breaking presentation at SID and featured presentation at the ATS Respiratory Innovation Summit highlight KT-621 BroADen Phase 1b clinical data and potential across Type 2 inflammatory diseases K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/15/3295720/0/en/Kymera-Therapeutics-Announces-Presentations-on-KT-621-a-First-In-Class-Oral-STAT6-Degrader-at-the-Society-for-Investigative-Dermatology-and-American-Thoracic-Society-Congresses.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","LU0072461881.USD","BK4115","LU0300736062.USD","BK4139","BK4096","LU1162221912.USD","BPH","LU0541502299.USD","ATS","BK4006","BK4588","LU1829250122.USD","PN","BK4585","BP","LU0320765646.SGD","LU0162691827.USD","BK4132","LU0006061336.USD","AD","LU0300736492.USD","BK4161","BK4201","SID","SG9999004220.SGD","KT","BK4107","KYMR","BK4117","LU0541501648.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634325894","title":"Kymera Therapeutics director Elena Ridloff disposes of 3,000 shares for $261,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2634325894","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634325894?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:59","pubTimestamp":1778533179,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics director Elena Ridloff sold 3,000 common shares on May 11, 2026 at USD 87, cutting direct holdings to 0 shares.Ridloff exercised stock options for 3,000 shares at USD 31.2 in a same-day transaction.Stock options beneficially owned fell to 13,000 following the exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL6V01Hk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Kymera Therapeutics director Elena Ridloff disposes of 3,000 shares for $261,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633315367","title":"Kymera Therapeutics Initiated at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2633315367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633315367?lang=en_us&edition=fundamental","pubTime":"2026-05-07 01:54","pubTimestamp":1778090040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYMR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 06, 2026 13:54 ET (17:54 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633632180","title":"Canaccord Genuity Initiates Kymera Therapeutics at Buy With $106 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2633632180","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633632180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:43","pubTimestamp":1778067794,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics (KYMR) has an average rating of buy and mean price target of $118.27, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633824931","title":"Kymera Therapeutics to join Bank of America Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633824931","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633824931?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:09","pubTimestamp":1778065742,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics to join fireside chat at Bank of America 2026 Healthcare Conference in Las Vegas on May 12 at 9:20 a.m. PT.Fireside chat also scheduled at RBC Capital Markets 2026 Global Healthcare Conference in New York on May 19 at 9 a.m. ET.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLtxdTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863902.USD","LU0648000940.SGD","BK4139","LU0070302665.USD","LU0130517989.USD","LU0306807586.USD","LU0321505439.SGD","IE00BKPKM429.USD","IE0001KFT4U8.USD","IE00BN0W2V16.EUR","LU0256863811.USD","LU1718418525.SGD","LU0477156797.USD","IE00BN0W2W23.USD","NDAQ","LU0980610538.SGD","LU1883839398.USD","KYMR","IE00B3QW5Z07.USD","LU0130103400.USD","LU0149725797.USD","LU0648001328.SGD","IE00BBT3K403.USD","IE00BGHQF748.EUR","LU1880398554.USD","IE00BZ1G4Q59.USD","SG9999014005.SGD","LU2210150020.SGD","IE00BKVL7J92.USD","LU0106831901.USD","LU0314104364.USD","BAC","LU2129689514.USD","BK4588","BK4207","IE0034235188.USD","LU1201861249.SGD","LU0417517546.SGD","IE00B19Z3581.USD","LU0320765489.SGD","LU1366192091.USD","LU2129689431.USD","BK4112","IE00B19Z3B42.SGD","IE00B64PRP62.GBP","BK4559","LU1804176565.USD","IE00B7SZLL34.SGD","LU0208291251.USD","LU0314106906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633827912","title":"Kymera says KT-579 Phase 1 healthy-volunteer trial data due in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633827912","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633827912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979443,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics highlighted new preclinical inflammatory bowel disease data for KT-579 at Digestive Disease Week 2026, with results already presented.Studies showed KT-579 delivered broad anti-inflammatory effects in an IBD model, with overall activity described as comparable or better than several established treatment approaches.Company also confirmed ongoing Phase 1 healthy-volunteer trial for oral KT-579, with data expected in 2H26.Readout is set to focus on safety and tolerability, with evidence of target degradation in blood intended to support further development in IBD and other autoimmune diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this n","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL3MPmcv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633491537","title":"Jeito Capital appoints Elaine Caughey partner for business development, investor relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2633491537","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633491537?lang=en_us&edition=fundamental","pubTime":"2026-05-05 17:46","pubTimestamp":1777974390,"startTime":"0","endTime":"0","summary":"Jeito Capital named Elaine Caughey partner for business development and investor relations, strengthening dealmaking support for portfolio companies and expanding investor engagement.Caughey was deputy chief operating officer at Blackstone Life Sciences, previously served as chief business officer at Kymera Therapeutics, held senior business development roles at Biogen.Sarah Shackelton joined as partner, talent, focusing on leadership due diligence, executive hiring, board build-outs across portfolio.Shackelton was chief talent officer at Oxford Science Enterprises, previously partner for marketing and talent at Abingworth, earlier worked in executive search at Coulter Partners, Spencer Stuart.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL14zhNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU0234570918.USD","LU0889565916.HKD","BK4533","BK4532","IE00B19Z9Z06.USD","BIIB","IE00B19Z9P08.USD","BK4588","BK4139","IE00B894F039.SGD","BK4585","LU0320765992.SGD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632095690","title":"Barclays Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632095690","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632095690?lang=en_us&edition=fundamental","pubTime":"2026-05-01 15:59","pubTimestamp":1777622344,"startTime":"0","endTime":"0","summary":"In a report released today, Eliana Merle from Barclays maintained a Buy rating on Kymera Therapeutics, with a price target of $133.00. According to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-kymera-therapeutics-kymr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-kymera-therapeutics-kymr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632865048","title":"Kymera Therapeutics price target lowered to $119 from $123 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2632865048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632865048?lang=en_us&edition=fundamental","pubTime":"2026-05-01 02:14","pubTimestamp":1777572862,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer lowered the firm’s price target on Kymera Therapeutics (KYMR) to $119 from $123 and keeps an Overweight rating...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-price-target-lowered-to-119-from-123-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kymera-therapeutics-price-target-lowered-to-119-from-123-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631393336","title":"Earnings Flash (KYMR) Kymera Therapeutics Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.88 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2631393336","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631393336?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:27","pubTimestamp":1777548426,"startTime":"0","endTime":"0","summary":"Earnings Flash (KYMR) Kymera Therapeutics Posts Q1 Net Loss $0.71 a Share, vs. FactSet Est of $0.88 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636092","title":"Kymera publishes corporate presentation on oral protein degraders for immunology medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636092","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636092?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:23","pubTimestamp":1777548204,"startTime":"0","endTime":"0","summary":"Kymera outlined strategy to develop oral targeted protein degraders aimed at delivering biologics-like activity in immunology.Lead program KT-621, an oral STAT6 degrader, is in Phase 2b trials in atopic dermatitis with data expected by mid-2027.KT-621 Phase 2b asthma trial remains ongoing with data expected in late 2027.Pipeline update highlighted KT-579, an oral IRF5 degrader, with Phase 1 healthy-volunteer data expected in 2H26.Kymera also flagged KT-485, an oral IRAK4 degrader, with Phase 1 start planned for 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL87lqVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631362406","title":"Kymera Therapeutics Q1 EPS $(0.71) Beats $(0.88) Estimate, Sales $34.365M Beat $8.614M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631362406","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631362406?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:21","pubTimestamp":1777548075,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics (NASDAQ:KYMR) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.88) by 19.32 percent. This is a 13.41 percent increase over losses of $(0.82) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52165325/kymera-therapeutics-q1-eps-0-71-beats-0-88-estimate-sales-34-365m-beat-8-614m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636374","title":"Kymera Q1 revenue jumps on Gilead milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636374","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636374?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:09","pubTimestamp":1777547380,"startTime":"0","endTime":"0","summary":"Kymera Q1 revenue jumps on Gilead milestoneOverviewUS biopharma firm's Q1 revenue rose sharply, beating analyst expectationsNet loss widened in Q1 as R&D and G&A expenses increasedCompany received $45","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nL1N41D0NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455277.USD","LU0965509283.SGD","LU0823416689.USD","LU2324357040.USD","BK4532","LU1430594728.SGD","LU2089984988.USD","SG9999015978.USD","LU0122379950.USD","BK4583","LU0889565916.HKD","LU1066053197.SGD","LU0058720904.USD","LU1061106388.HKD","LU0965509010.AUD","LU2112291526.USD","LU0965509101.SGD","LU1037948897.HKD","LU1571399168.USD","LU1778281490.HKD","BK4568","KYMR","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1839511570.USD","SG9999015945.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","LU1585245621.USD","LU0320765992.SGD","GILD","LU1057294990.SGD","LU0861579265.USD","BK4588","BK4566","SG9999015952.SGD","LU1023059063.AUD","LU2087621335.USD","LU1066051498.USD","LU1674673428.USD","BK4139","LU0882574055.USD","LU0965508806.USD","LU0114720955.EUR","LU1674673691.USD","IE00B19Z3B42.SGD","SG9999015986.USD","BK4550","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631563506","title":"Kymera Q1 net loss widens to $69.2 million; collaboration revenues climb to $34.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631563506","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631563506?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:06","pubTimestamp":1777547181,"startTime":"0","endTime":"0","summary":"Kymera posted a net loss of USD 69.2 million for Q1 2026.Revenue rose to USD 34.4 million from collaboration revenue.R&D expenses climbed to USD 98.2 million due to higher investment in STAT6 plus platform and discovery programs.Cash, cash equivalents and investments totaled USD 1.55 billion as of March 31, 2026.Pipeline progress included ongoing Phase 2b KT-621 trials with atopic dermatitis data expected mid-2027 and asthma data expected late 2027.FDA granted Fast Track designation to KT-621 for moderate to severe eosinophilic asthma.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3qbbrw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BN0W2T93.GBP","KYMR","LU2210150020.SGD","BK4585","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","NDAQ","BK4588","BK4112","LU0314104364.USD","BK4139","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635549","title":"BRIEF-Kymera Therapeutics Q1 EPS USD -0.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635549","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635549?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546845,"startTime":"0","endTime":"0","summary":"BRIEF-Kymera Therapeutics Q1 EPS USD -0.71\n\n\nApr 30 (Reuters) - Kymera Therapeutics Q1 revenue USD 34.365 million vs. IBES estimate USD 8.61 million.\n\nQ1 operating expenses USD 118.519 million\nQ1 net income USD -69.234 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX759C47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631636287","title":"Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2631636287","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631636287?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:00","pubTimestamp":1777546800,"startTime":"0","endTime":"0","summary":"KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively FDA granted Fast Track designation to K","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284687/0/en/Kymera-Therapeutics-Announces-First-Quarter-2026-Financial-Results-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","BK4139","BK4096","LU1162221912.USD","BPH","ATS","BK4006","BK4588","LU1829250122.USD","PN","BK4585","BP","LU0320765646.SGD","LU0162691827.USD","IBD","BK4132","LU0006061336.USD","AD","BK4161","RA","BK4201","SID","EASI","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631352494","title":"Kymera CEO Nello Mainolfi disposes of common shares worth $2,430,898.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2631352494","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631352494?lang=en_us&edition=fundamental","pubTime":"2026-04-30 05:10","pubTimestamp":1777497020,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics CEO Nello Mainolfi exercised stock options for 30,000 shares at $2.08 on April 29, 2026.Mainolfi sold 30,000 shares on April 29, 2026 at weighted average prices of $80.74 to $82.45.Directly held Kymera common stock following transactions totaled 666,195 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL21xdmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kymera CEO Nello Mainolfi disposes of common shares worth $2,430,898.39","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630141827","title":"Kymera director Bruce Booth disposes of common shares worth $538,687","url":"https://stock-news.laohu8.com/highlight/detail?id=2630141827","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630141827?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:36","pubTimestamp":1777062961,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics director Bruce Booth sold 5,900 shares Apr. 22 at weighted average price USD 89.96.Transaction followed option exercises totaling 5,900 shares at USD 14.18 and USD 20.Booth ended day with 0 shares held directly.Separate indirect holdings fell by 100 shares to 3,899,829 shares and 674,944 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL2tsb9r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":161,"code":"91000000","status":"200"}]}}